Costco: Patient Investors Know the Bear Case (NASDAQ: COST)

The article flags Costco’s valuation risk: shares trade at ~48.4x P/E vs ~26x for the S&P 500 (an ~86% premium), leaving “no margin of safety.” Positively, Costco’s model remains strong with fiscal 2025 net sales of $269.9B, 82.9M membership households, and a 92.2% U.S./Canada renewal rate, plus no same-store sales declines in the last fiscal year. Net takeaway: add to a watch list for patient investors, with a potential entry case if P/E contracts to 35 or below.

Analysis

The market is paying for COST as a quasi-bond proxy, which means the stock’s real risk is not earnings collapse but multiple compression. At ~48x earnings, the burden of proof is on management to keep high-single-digit comp growth, membership economics, and margin discipline perfectly intact; even a small miss can cause outsized de-rating because there is little valuation cushion.

Second-order, the moat is likely to remain intact, but the upside is increasingly constrained by scale itself: a bigger base makes incremental growth harder to surprise on the upside. If consumer demand slows, COST may still outperform fundamentals, but the stock can underperform on a relative basis as capital rotates to cheaper defensives like WMT or to retailers with more operating leverage. Vendors also have limited bargaining power here, so margin pressure should show up first in peers before it hits COST, making supplier weakness a useful early warning signal.

Contrarian read: consensus is focused on quality durability and may be underweighting how much of that durability is already capitalized. The most likely reversal catalyst is not a macro shock but a routine quarter where renewal rates, fee-income growth, or traffic decelerate just enough to question the premium. Over 6-18 months, if rates fall and equities re-rate toward growth, COST’s defensive premium could still compress even without any fundamental deterioration.

Key Decisions for Investors

• Do not initiate a fresh outright long in COST here; wait for either a 10-15% pullback or a forward P/E reset toward ~35x before adding. At current valuation, the expected return is dominated by multiple risk, not earnings upside.
• Best relative-value expression: short COST / long WMT on a 3-6 month horizon. WMT offers similar defensive exposure with a materially less demanding valuation, while COST carries the higher de-rating risk if the market rotates out of premium defensives.
• If you want convexity, use a 3-6 month COST put spread into the next earnings window rather than stock shorting. The thesis is a modest miss or softer guidance causing a 10-15% drawdown, with defined risk if the premium persists.
• Set an alert on membership renewal rate and fee-income growth in the next quarterly print. Any sign of deceleration there is the first real falsifier for the premium-multiple thesis and should trigger covering shorts / abandoning the relative-value trade.